Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetrandrine Adjuvant Treatment for COVID-19
NCT04308317Phase 4Unknown
- Sponsor
- Henan Provincial People's Hospital
- Start
- Mar 2020
- Primary completion
- Mar 2021
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tetrandrine in coronavirus disease 2019 (COVID-19), sponsored by Henan Provincial People's Hospital. Status: unknown.
02
Drugs
tetrandrine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04308317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04308317.